• Study on Blood Thinners Apixaban, Edoxaban, Rivaroxaban, and Acetylsalicylic Acid for Patients with Aortic Stenosis After Heart Valve Replacement

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Norway
  • Study of Fedratinib and Nivolumab for Patients with Myelofibrosis Resistant to JAK-inhibitor Treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on the Impact of Fluoroestradiol F-18 PET on Treatment for Patients with ER+ HER2- Metastatic Breast Cancer After First-Line Hormone Therapy Relapse

    Not recruiting

    3 1 1 1
    Investigated drugs:
    France
  • Study on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Germany Greece Hungary +4
  • Study on Atezolizumab, Carboplatin, and Etoposide for Adults with Advanced Large-Cell Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1 1
    Germany
  • Study on Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone for Multiple Myeloma Patients Not Eligible for Transplant

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Liver Transplantation: Comparing Custodiol-N Solution with a Drug Combination for Organ Preservation in Patients Undergoing Liver Transplant Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on Dupilumab for Treating Nummular Eczema in Patients

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study on Preoperative Treatment with Gemcitabine, Cisplatin, Durvalumab, and Tremelimumab for Patients with Intrahepatic Cholangiocarcinoma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Germany
  • Study on Low-Dose Atropine Sulfate Eye Drops for Controlling Progressive Myopia in Caucasian Children

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Germany

powered by